Evidence map›Paper›PMID 30903954›Full record

ReviewHearing research2019

Translating animal models to human therapeutics in noise-induced and age-related hearing loss.

Sharon G Kujawa, M Charles Liberman

Registry-linked trialAbstract readReview
In one paragraph

Review in Hearing research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06729632 (Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss), which is not on this map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06729632 narecruitingnot on this mapstarted 2024, after this paper: background citation

Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss

TypeinterventionalSponsorRestorear Devices LLCRan2024 to 2027Enrolled116ConditionsNoise Exposure, Noise-induced Hearing Loss, Noise, Adverse EffectArmsCold pack-delivered mild therapeutic hypothermia
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. N-acetylcysteine for the Prevention of Cisplatin-Induced Hearing Loss: A Systematic Review and Meta-analysis.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Lateral olivocochlear neurons modulate cochlear responses to noise exposure.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
  14. The curvature quantification of wave I in auditory brainstem responses detects cochlear synaptopathy in human beings.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  15. Hearing Loss and Oxidative Stress: A Comprehensive Review.Antioxidants (Basel, Switzerland) · 2024
    Review
  16. Review
  17. Modern In Vitro Techniques for Modeling Hearing Loss.Bioengineering (Basel, Switzerland) · 2024
    Review
  18. Article
  19. NADPH Oxidase 3: Beyond the Inner Ear.Antioxidants (Basel, Switzerland) · 2024
    Review
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sharon G KujawaDepartment of Otolaryngology, Harvard Medical School, Eaton-Peabody Laboratories, Massachusetts Eye & Ear Infirmary, Boston, 02114-3096, MA, USA. Electronic address: Sharon_Kujawa@meei.harvard.edu.
M Charles LibermanDepartment of Otolaryngology, Harvard Medical School, Eaton-Peabody Laboratories, Massachusetts Eye & Ear Infirmary, Boston, 02114-3096, MA, USA.

Funding

Synaptopathy, Neural Pathophysiology and Suprathreshold Processing in Gerbils with Normal or Elevated ThresholdsP50DC015857 · NIDCD · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Sharon G Kujawa · 2017 to 2026
$28.1M
SINGLE-NEURON MARKING IN THE STUDY OF ABNORMAL COCHLEASR01DC000188 · NIDCD · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Gabriel Corfas, M. Charles Liberman · 1989 to 2026
$15.1M
Imaging Core PlanP30DC005209 · NIDCD · MASSACHUSETTS EYE AND EAR INFIRMARY · PI LIBERMAN, M. CHARLES · 2002 to 2016
$12.0M
NIDCD NIH HHS P30 DC005209NIDCD NIH HHS P50 DC015857NIDCD NIH HHS R01 DC000188
6 · The paper itself

Abstract

Acquired sensorineural hearing loss is one of the most prevalent chronic diseases, and aging and acoustic overexposure are common contributors. Decades of study in animals and humans have clarified the cellular targets and perceptual consequences of these forms of hearing loss, and preclinical studies have led to the development of therapeutics designed to slow, prevent or reverse them. Here, we review the histopathological changes underlying age-related and noise-induced hearing loss and the functional consequences of these pathologies. Based on these relations, we consider the ambiguities that arise in diagnosing underlying pathology from minimally invasive tests of auditory function, and how those ambiguities present challenges in the design and interpretation of clinical trials.

Indexed as

Translational Research, BiomedicalAge FactorsAgingAnimalsAuditory PerceptionCochleaDisease Models, AnimalHearingHearing Loss, Noise-InducedHumansNoisePresbycusisSpecies SpecificityAge-related hearing lossCochlear drug therapyCochlear synaptopathyNoise-induced hearing lossSensorineural hearing loss

Identifiers

PMID30903954
PMCPMC6534965

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.